Almost all the drugs that are widely used today against Plasmodium spp., the causative agent of malaria, target the asexual blood stages of the parasite. Widespread drug resistance severely restricts ...

Please provide your email address to receive an email when new articles are posted on . According to WHO, progress against malaria has stalled and the disease remains a global health concern, causing ...

The tenacity of the malaria parasite has all too often made it intractable to long-term therapeutic intervention. The development of parasite drug resistance is almost an inevitability, causing public ...

NAIROBI, Kenya, November 2, 2009 – Marking its tenth anniversary year, the PATH Malaria Vaccine Initiative (MVI) today unveiled a new strategy that sets the stage for an aggressive push targeting the ...